The Prescription Pain Relievers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Prescription Pain Relievers size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Prescription Pain Relievers market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Prescription Pain Relievers market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Generic Opioids
Branded Opioids
NSAIDs
Others
Market segment by Application, can be divided into
Hospitals
Clinics
Drugstores
Market segment by players, this report covers
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Prescription Pain Relievers
1.2 Classification of Prescription Pain Relievers by Type
1.2.1 Overview: Global Prescription Pain Relievers Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prescription Pain Relievers Revenue Market Share by Type in 2020
1.2.3 Generic Opioids
1.2.4 Branded Opioids
1.2.5 NSAIDs
1.2.6 Others
1.3 Global Prescription Pain Relievers Market by Application
1.3.1 Overview: Global Prescription Pain Relievers Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 Global Prescription Pain Relievers Market Size & Forecast
1.5 Global Prescription Pain Relievers Market Size and Forecast by Region
1.5.1 Global Prescription Pain Relievers Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prescription Pain Relievers Market Size by Region, (2016-2021)
1.5.3 North America Prescription Pain Relievers Market Size and Prospect (2016-2026)
1.5.4 Europe Prescription Pain Relievers Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prescription Pain Relievers Market Size and Prospect (2016-2026)
1.5.6 South America Prescription Pain Relievers Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prescription Pain Relievers Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prescription Pain Relievers Market Drivers
1.6.2 Prescription Pain Relievers Market Restraints
1.6.3 Prescription Pain Relievers Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Prescription Pain Relievers Product and Solutions
2.1.4 Pfizer Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Prescription Pain Relievers Product and Solutions
2.2.4 GSK Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GSK Recent Developments and Future Plans
2.3 Grunenthal
2.3.1 Grunenthal Details
2.3.2 Grunenthal Major Business
2.3.3 Grunenthal Prescription Pain Relievers Product and Solutions
2.3.4 Grunenthal Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Grunenthal Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Prescription Pain Relievers Product and Solutions
2.4.4 Bayer Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Prescription Pain Relievers Product and Solutions
2.5.4 Sanofi Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Prescription Pain Relievers Product and Solutions
2.6.4 Eli Lilly Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Prescription Pain Relievers Product and Solutions
2.7.4 AstraZeneca Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 AstraZeneca Recent Developments and Future Plans
2.8 Endo
2.8.1 Endo Details
2.8.2 Endo Major Business
2.8.3 Endo Prescription Pain Relievers Product and Solutions
2.8.4 Endo Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Endo Recent Developments and Future Plans
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Prescription Pain Relievers Product and Solutions
2.9.4 Merck Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Merck Recent Developments and Future Plans
2.10 Depomed
2.10.1 Depomed Details
2.10.2 Depomed Major Business
2.10.3 Depomed Prescription Pain Relievers Product and Solutions
2.10.4 Depomed Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Depomed Recent Developments and Future Plans
2.11 Yunnan Baiyao
2.11.1 Yunnan Baiyao Details
2.11.2 Yunnan Baiyao Major Business
2.11.3 Yunnan Baiyao Prescription Pain Relievers Product and Solutions
2.11.4 Yunnan Baiyao Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Yunnan Baiyao Recent Developments and Future Plans
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Prescription Pain Relievers Product and Solutions
2.12.4 Teva Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Teva Recent Developments and Future Plans
2.13 J&J
2.13.1 J&J Details
2.13.2 J&J Major Business
2.13.3 J&J Prescription Pain Relievers Product and Solutions
2.13.4 J&J Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 J&J Recent Developments and Future Plans
2.14 Allergan
2.14.1 Allergan Details
2.14.2 Allergan Major Business
2.14.3 Allergan Prescription Pain Relievers Product and Solutions
2.14.4 Allergan Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Allergan Recent Developments and Future Plans
2.15 Purdue
2.15.1 Purdue Details
2.15.2 Purdue Major Business
2.15.3 Purdue Prescription Pain Relievers Product and Solutions
2.15.4 Purdue Prescription Pain Relievers Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Purdue Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prescription Pain Relievers Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Prescription Pain Relievers Players Market Share
3.2.2 Top 10 Prescription Pain Relievers Players Market Share
3.2.3 Market Competition Trend
3.3 Prescription Pain Relievers Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prescription Pain Relievers Revenue and Market Share by Type (2016-2021)
4.2 Global Prescription Pain Relievers Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prescription Pain Relievers Revenue Market Share by Application (2016-2021)
5.2 Prescription Pain Relievers Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prescription Pain Relievers Revenue by Type (2016-2026)
6.2 North America Prescription Pain Relievers Revenue by Application (2016-2026)
6.3 North America Prescription Pain Relievers Market Size by Country
6.3.1 North America Prescription Pain Relievers Revenue by Country (2016-2026)
6.3.2 United States Prescription Pain Relievers Market Size and Forecast (2016-2026)
6.3.3 Canada Prescription Pain Relievers Market Size and Forecast (2016-2026)
6.3.4 Mexico Prescription Pain Relievers Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prescription Pain Relievers Revenue by Type (2016-2026)
7.2 Europe Prescription Pain Relievers Revenue by Application (2016-2026)
7.3 Europe Prescription Pain Relievers Market Size by Country
7.3.1 Europe Prescription Pain Relievers Revenue by Country (2016-2026)
7.3.2 Germany Prescription Pain Relievers Market Size and Forecast (2016-2026)
7.3.3 France Prescription Pain Relievers Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prescription Pain Relievers Market Size and Forecast (2016-2026)
7.3.5 Russia Prescription Pain Relievers Market Size and Forecast (2016-2026)
7.3.6 Italy Prescription Pain Relievers Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prescription Pain Relievers Revenue by Type (2016-2026)
8.2 Asia-Pacific Prescription Pain Relievers Revenue by Application (2016-2026)
8.3 Asia-Pacific Prescription Pain Relievers Market Size by Region
8.3.1 Asia-Pacific Prescription Pain Relievers Revenue by Region (2016-2026)
8.3.2 China Prescription Pain Relievers Market Size and Forecast (2016-2026)
8.3.3 Japan Prescription Pain Relievers Market Size and Forecast (2016-2026)
8.3.4 South Korea Prescription Pain Relievers Market Size and Forecast (2016-2026)
8.3.5 India Prescription Pain Relievers Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prescription Pain Relievers Market Size and Forecast (2016-2026)
8.3.7 Australia Prescription Pain Relievers Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prescription Pain Relievers Revenue by Type (2016-2026)
9.2 South America Prescription Pain Relievers Revenue by Application (2016-2026)
9.3 South America Prescription Pain Relievers Market Size by Country
9.3.1 South America Prescription Pain Relievers Revenue by Country (2016-2026)
9.3.2 Brazil Prescription Pain Relievers Market Size and Forecast (2016-2026)
9.3.3 Argentina Prescription Pain Relievers Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prescription Pain Relievers Revenue by Type (2016-2026)
10.2 Middle East & Africa Prescription Pain Relievers Revenue by Application (2016-2026)
10.3 Middle East & Africa Prescription Pain Relievers Market Size by Country
10.3.1 Middle East & Africa Prescription Pain Relievers Revenue by Country (2016-2026)
10.3.2 Turkey Prescription Pain Relievers Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prescription Pain Relievers Market Size and Forecast (2016-2026)
10.3.4 UAE Prescription Pain Relievers Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Prescription Pain Relievers Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prescription Pain Relievers Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prescription Pain Relievers Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prescription Pain Relievers Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prescription Pain Relievers Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Prescription Pain Relievers Product and Solutions
Table 9. Pfizer Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GSK Corporate Information, Head Office, and Major Competitors
Table 11. GSK Major Business
Table 12. GSK Prescription Pain Relievers Product and Solutions
Table 13. GSK Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Grunenthal Corporate Information, Head Office, and Major Competitors
Table 15. Grunenthal Major Business
Table 16. Grunenthal Prescription Pain Relievers Product and Solutions
Table 17. Grunenthal Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bayer Corporate Information, Head Office, and Major Competitors
Table 19. Bayer Major Business
Table 20. Bayer Prescription Pain Relievers Product and Solutions
Table 21. Bayer Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sanofi Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi Major Business
Table 24. Sanofi Prescription Pain Relievers Product and Solutions
Table 25. Sanofi Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly Major Business
Table 28. Eli Lilly Prescription Pain Relievers Product and Solutions
Table 29. Eli Lilly Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 31. AstraZeneca Major Business
Table 32. AstraZeneca Prescription Pain Relievers Product and Solutions
Table 33. AstraZeneca Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Endo Corporate Information, Head Office, and Major Competitors
Table 35. Endo Major Business
Table 36. Endo Prescription Pain Relievers Product and Solutions
Table 37. Endo Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Merck Corporate Information, Head Office, and Major Competitors
Table 39. Merck Major Business
Table 40. Merck Prescription Pain Relievers Product and Solutions
Table 41. Merck Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Depomed Corporate Information, Head Office, and Major Competitors
Table 43. Depomed Major Business
Table 44. Depomed Prescription Pain Relievers Product and Solutions
Table 45. Depomed Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Yunnan Baiyao Corporate Information, Head Office, and Major Competitors
Table 47. Yunnan Baiyao Major Business
Table 48. Yunnan Baiyao Prescription Pain Relievers Product and Solutions
Table 49. Yunnan Baiyao Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Teva Corporate Information, Head Office, and Major Competitors
Table 51. Teva Major Business
Table 52. Teva Prescription Pain Relievers Product and Solutions
Table 53. Teva Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. J&J Corporate Information, Head Office, and Major Competitors
Table 55. J&J Major Business
Table 56. J&J Prescription Pain Relievers Product and Solutions
Table 57. J&J Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Allergan Corporate Information, Head Office, and Major Competitors
Table 59. Allergan Major Business
Table 60. Allergan Prescription Pain Relievers Product and Solutions
Table 61. Allergan Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Purdue Corporate Information, Head Office, and Major Competitors
Table 63. Purdue Major Business
Table 64. Purdue Prescription Pain Relievers Product and Solutions
Table 65. Purdue Prescription Pain Relievers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Prescription Pain Relievers Revenue (USD Million) by Players (2019-2021)
Table 67. Global Prescription Pain Relievers Revenue Share by Players (2019-2021)
Table 68. Breakdown of Prescription Pain Relievers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Prescription Pain Relievers Players Head Office, Products and Services Provided
Table 70. Prescription Pain Relievers Mergers & Acquisitions in the Past Five Years
Table 71. Prescription Pain Relievers New Entrants and Expansion Plans
Table 72. Global Prescription Pain Relievers Revenue (USD Million) by Type (2016-2021)
Table 73. Global Prescription Pain Relievers Revenue Share by Type (2016-2021)
Table 74. Global Prescription Pain Relievers Revenue Forecast by Type (2021-2026)
Table 75. Global Prescription Pain Relievers Revenue by Application (2016-2021)
Table 76. Global Prescription Pain Relievers Revenue Forecast by Application (2021-2026)
Table 77. North America Prescription Pain Relievers Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Prescription Pain Relievers Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Prescription Pain Relievers Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Prescription Pain Relievers Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Prescription Pain Relievers Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Prescription Pain Relievers Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Prescription Pain Relievers Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Prescription Pain Relievers Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Prescription Pain Relievers Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Prescription Pain Relievers Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Prescription Pain Relievers Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Prescription Pain Relievers Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Prescription Pain Relievers Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Prescription Pain Relievers Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Prescription Pain Relievers Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Prescription Pain Relievers Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Prescription Pain Relievers Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Prescription Pain Relievers Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Prescription Pain Relievers Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Prescription Pain Relievers Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Prescription Pain Relievers Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Prescription Pain Relievers Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Prescription Pain Relievers Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Prescription Pain Relievers Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Prescription Pain Relievers Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Prescription Pain Relievers Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Prescription Pain Relievers Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Prescription Pain Relievers Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Prescription Pain Relievers Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Prescription Pain Relievers Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prescription Pain Relievers Picture
Figure 2. Global Prescription Pain Relievers Revenue Market Share by Type in 2020
Figure 3. Generic Opioids
Figure 4. Branded Opioids
Figure 5. NSAIDs
Figure 6. Others
Figure 7. Prescription Pain Relievers Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Drugstores Picture
Figure 11. Global Prescription Pain Relievers Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Prescription Pain Relievers Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Prescription Pain Relievers Revenue Market Share by Region (2016-2026)
Figure 14. Global Prescription Pain Relievers Revenue Market Share by Region in 2020
Figure 15. North America Prescription Pain Relievers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Prescription Pain Relievers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Prescription Pain Relievers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Prescription Pain Relievers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Prescription Pain Relievers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Prescription Pain Relievers Market Drivers
Figure 21. Prescription Pain Relievers Market Restraints
Figure 22. Prescription Pain Relievers Market Trends
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. GSK Recent Developments and Future Plans
Figure 25. Grunenthal Recent Developments and Future Plans
Figure 26. Bayer Recent Developments and Future Plans
Figure 27. Sanofi Recent Developments and Future Plans
Figure 28. Eli Lilly Recent Developments and Future Plans
Figure 29. AstraZeneca Recent Developments and Future Plans
Figure 30. Endo Recent Developments and Future Plans
Figure 31. Merck Recent Developments and Future Plans
Figure 32. Depomed Recent Developments and Future Plans
Figure 33. Yunnan Baiyao Recent Developments and Future Plans
Figure 34. Teva Recent Developments and Future Plans
Figure 35. J&J Recent Developments and Future Plans
Figure 36. Allergan Recent Developments and Future Plans
Figure 37. Purdue Recent Developments and Future Plans
Figure 38. Global Prescription Pain Relievers Revenue Share by Players in 2020
Figure 39. Prescription Pain Relievers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Prescription Pain Relievers Revenue Market Share in 2020
Figure 41. Global Top 10 Players Prescription Pain Relievers Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Prescription Pain Relievers Revenue Share by Type in 2020
Figure 44. Global Prescription Pain Relievers Market Share Forecast by Type (2021-2026)
Figure 45. Global Prescription Pain Relievers Revenue Share by Application in 2020
Figure 46. Global Prescription Pain Relievers Market Share Forecast by Application (2021-2026)
Figure 47. North America Prescription Pain Relievers Sales Market Share by Type (2016-2026)
Figure 48. North America Prescription Pain Relievers Sales Market Share by Application (2016-2026)
Figure 49. North America Prescription Pain Relievers Revenue Market Share by Country (2016-2026)
Figure 50. United States Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Prescription Pain Relievers Sales Market Share by Type (2016-2026)
Figure 54. Europe Prescription Pain Relievers Sales Market Share by Application (2016-2026)
Figure 55. Europe Prescription Pain Relievers Revenue Market Share by Country (2016-2026)
Figure 56. Germany Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Prescription Pain Relievers Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Prescription Pain Relievers Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Prescription Pain Relievers Revenue Market Share by Region (2016-2026)
Figure 64. China Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Prescription Pain Relievers Sales Market Share by Type (2016-2026)
Figure 71. South America Prescription Pain Relievers Sales Market Share by Application (2016-2026)
Figure 72. South America Prescription Pain Relievers Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Prescription Pain Relievers Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Prescription Pain Relievers Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Prescription Pain Relievers Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Prescription Pain Relievers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source